Investing

Novo Nordisk Stock: The AI Case Wall Street May Be Missing

Eric Fry sees a potential comeback story in obesity pills, faster drug research, and a profitable business investors have punished

Source link

Share with your friends!

Leave a Reply

Your email address will not be published. Required fields are marked *